Challenges in Drug Design

 Any drug that is taken undergoes a number of chemical reactions in the liver as the body attempts to neutralize foreign substances.  This set of reactions is well characterized, and a great deal of knowledge exists as to how drugs are modified as the body eliminates them.  More importantly, various chemical structures are highly toxic to biological systems, and these are also well characterized.  These constraints must also be taken under consideration as novel drugs are developed. The annual decline in the number of drugs approved for release onto the market in recent years has put pressure on you and your team to refine the drug discovery process and use more effective methods to discover a higher number of successful lead compounds.

 

  • Structure based strategies
  • Carbon nano tubes (CNTS)
  • parallel drug designs

Related Conference of Challenges in Drug Design

December 14-14, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
April 24-24, 2021

2nd International Conference on Nucleic Acids

London, UK
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Challenges in Drug Design Conference Speakers

Recommended Sessions

Related Journals

Are you interested in